Bellicum Pharmaceuticals' Series B Round

Bellicum Pharmaceuticals raised a round of funding on March 08, 2012.

Bellicum Pharmaceuticals is developing safer and more effective cell therapies to treat cancers and other chronic and life-threatening diseases. The Company's cell-based therapies incorporate either t…

Articles about Bellicum Pharmaceuticals' Series B Round: